The chart below shows how IMCC performed 10 days before and after its earnings report, based on data from the past quarters. Typically, IMCC sees a -6.72% change in stock price 10 days leading up to the earnings, and a -9.76% change 10 days following the report. On the earnings day itself, the stock moves by +2.91%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Q3 Revenue Increase: Our revenue in Q3 increased by 12.2% versus Q3 2023.
German Revenue Surge: This growth was driven mainly by an increase of 278% in the German revenue.
Dried Flower Price Increase: Our selling price per gram of dried flower increased 42% in this time period to $6.2 per gram.
Operating Expenses Decrease: In addition, our operating expenses decreased by 16% versus Q3 2023.
Inventory Management Strategy: We continue to closely monitor our inventory and accrued for about $0.6 million for slow moving stock.
Negative
Net Loss Comparison: Our net loss in the nine months ended September 30, 2024 was $10.6 million compared to $6.7 million in the nine months ended September 30, 2023.
Net Loss Comparison: Net loss in Q3 2024 was $1.1 million compared to $2.1 million in Q3 2023.
EBITDA Loss Increase: Non-IFRS adjusted EBITDA loss for the nine months ended September 30, 2024 was $4.7 million compared with $3.7 million representing an increase of 25%.
Diluted Loss Per Share: Diluted loss per share for the nine months ended September 30, 2024 was $4.29 compared to a loss of $2.95 per share in the same period for year 2023.
Asset Decrease Analysis: The decrease in total assets as of September 30, 2024 was mainly attributed to the Oranim agreement cancellation of $9.5 million.
IM Cannabis Corp. (IMCC) Q3 2024 Earnings Call Transcript
IMCC.O
-5.42%